Maynard Um
-
-
-
-
-
-
-
Precigen Reports 'Robust Uptake' of New Drug for Rare Respiratory Disease; First Quarter Revenue Expected to Top $18 Million
-
-
-
-
-
-
-
Precigen reports sustained responses for RRP therapy PAPZIMEOS
-
-
-
-
-
-
-
Citizens JMP Reiterates Market Outperform Rating on Precigen Inc. (PGEN)
-
-
-
-
-
-
-
Stifel Reiterates Buy Rating on Precigen Inc. (PGEN)
-
-
-
-
-
-
-
Precigen Inc. (PGEN) PT Lowered to $4 at H.C. Wainwright
-
-
-
-
-
396,364 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

